118 related articles for article (PubMed ID: 10952611)
1. Antimalarial activities of aminooxy compounds.
Berger BJ
Antimicrob Agents Chemother; 2000 Sep; 44(9):2540-2. PubMed ID: 10952611
[TBL] [Abstract][Full Text] [Related]
2. Combined action of inhibitors of polyamine biosynthetic pathway with a known antimalarial drug chloroquine on Plasmodium falciparum.
Das B; Gupta R; Madhubala R
Pharmacol Res; 1995; 31(3-4):189-93. PubMed ID: 7630858
[TBL] [Abstract][Full Text] [Related]
3. Novel Synthetic Polyamines Have Potent Antimalarial Activities
El Bissati K; Redel H; Ting LM; Lykins JD; McPhillie MJ; Upadhya R; Woster PM; Yarlett N; Kim K; Weiss LM
Front Cell Infect Microbiol; 2019; 9():9. PubMed ID: 30838177
[TBL] [Abstract][Full Text] [Related]
4. Combined action of inhibitors of S-adenosylmethionine decarboxylase with an antimalarial drug, chloroquine, on Plasmodium falciparum.
Das B; Gupta R; Madhubala R
J Eukaryot Microbiol; 1997; 44(1):12-7. PubMed ID: 9172828
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum and Plasmodium berghei: effects of ornithine decarboxylase inhibitors on erythrocytic schizogony.
Bitonti AJ; McCann PP; Sjoerdsma A
Exp Parasitol; 1987 Oct; 64(2):237-43. PubMed ID: 3115816
[TBL] [Abstract][Full Text] [Related]
6. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Nakornchai S; Konthiang P
Acta Trop; 2006 Dec; 100(3):185-91. PubMed ID: 17126280
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the ornithine aminotransferase from Plasmodium falciparum.
Gafan C; Wilson J; Berger LC; Berger BJ
Mol Biochem Parasitol; 2001 Nov; 118(1):1-10. PubMed ID: 11704268
[TBL] [Abstract][Full Text] [Related]
8. Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds.
Crowther GJ; Napuli AJ; Gilligan JH; Gagaring K; Borboa R; Francek C; Chen Z; Dagostino EF; Stockmyer JB; Wang Y; Rodenbough PP; Castaneda LJ; Leibly DJ; Bhandari J; Gelb MH; Brinker A; Engels IH; Taylor J; Chatterjee AK; Fantauzzi P; Glynne RJ; Van Voorhis WC; Kuhen KL
Mol Biochem Parasitol; 2011 Jan; 175(1):21-9. PubMed ID: 20813141
[TBL] [Abstract][Full Text] [Related]
9. Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target.
Müller IB; Das Gupta R; Lüersen K; Wrenger C; Walter RD
Mol Biochem Parasitol; 2008 Jul; 160(1):1-7. PubMed ID: 18455248
[TBL] [Abstract][Full Text] [Related]
10. 3-Aminooxy-1-aminopropane and derivatives have an antiproliferative effect on cultured Plasmodium falciparum by decreasing intracellular polyamine concentrations.
Das Gupta R; Krause-Ihle T; Bergmann B; Müller IB; Khomutov AR; Müller S; Walter RD; Lüersen K
Antimicrob Agents Chemother; 2005 Jul; 49(7):2857-64. PubMed ID: 15980361
[TBL] [Abstract][Full Text] [Related]
11. Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with alpha-difluoromethylornithine cure murine malaria.
Bitonti AJ; Dumont JA; Bush TL; Edwards ML; Stemerick DM; McCann PP; Sjoerdsma A
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):651-5. PubMed ID: 2463635
[TBL] [Abstract][Full Text] [Related]
12. Synergism of antimalarial antibiotics with hydrogen peroxide in inhibiting Plasmodium falciparum growth in culture.
Utaida S; Auparakkitanon S; Wilairat P
Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):1-5. PubMed ID: 24964646
[TBL] [Abstract][Full Text] [Related]
13. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimalarial interactions between mefloquine and cytochrome P450 inhibitors.
Wisedpanichkij R; Chaijaroenkul W; Sangsuwan P; Tantisawat J; Boonprasert K; Na-Bangchang K
Acta Trop; 2009 Oct; 112(1):12-5. PubMed ID: 19497287
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
van Zyl RL; Havlik I; Monteagudo FS
J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
[TBL] [Abstract][Full Text] [Related]
16. Poisoning pyridoxal 5-phosphate-dependent enzymes: a new strategy to target the malaria parasite Plasmodium falciparum.
Müller IB; Wu F; Bergmann B; Knöckel J; Walter RD; Gehring H; Wrenger C
PLoS One; 2009; 4(2):e4406. PubMed ID: 19197387
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum: synchronization of cultures with DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
Assaraf YG; Golenser J; Spira DT; Bachrach U
Exp Parasitol; 1986 Apr; 61(2):229-35. PubMed ID: 3082665
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
Kreidenweiss A; Kremsner PG; Mordmüller B
Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
[TBL] [Abstract][Full Text] [Related]
19. Mode of inhibition of ornithine aminotransferase by L-canaline.
Kito K; Sanada Y; Katunuma N
J Biochem; 1978 Jan; 83(1):201-6. PubMed ID: 624704
[TBL] [Abstract][Full Text] [Related]
20. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
